Healthcare -
Biotechnology - NASDAQ - US
$ 0.3269
-7.84 %
$ 40.7 M
Market Cap
-0.58
P/E
MRSN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MRSN - Mersana Therapeutics, Inc.
4.09 M
LAST VALUE
-83.65%
2 YEAR CAGR
-46.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR